mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

DNA Methylation as a Therapeutic Target in Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Semaphorin 7A as a Potential Immune Regulator and Promising Therapeutic Target in Rheumatoid Arthritis

Arthritis Research & Therapy
2017English

Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target

Frontiers in Immunology
AllergyImmunology
2018English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

AAPS Journal
Pharmaceutical Science
2016English

OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

cMET as a Potential Therapeutic Target in Gastric Cancer (Review)

International Journal of Molecular Medicine
MedicineGenetics
2013English

Analysis of Tim-3 as a Therapeutic Target in Prostate Cancer

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy